"Viruses modified to selectively kill cancer cells"

Copyright: Panos.
Copyright: Panos.

A leading source of news, views and analysis on information about science and technology for global development, SciDev.Net, reports on the research performed by IDIBAPS and IRB Barcelona scientists.  

In the study, co-led by Raúl Méndez, ICREA researcher at IRB Barcelona, and Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, researchers have designed a new strategy to achieve genetically modified viruses that selectively attack tumor cells without affecting healthy tissues. 

“What makes our approach different is the mechanism by which the virus acquires oncoselectivity,” Cristina Fillat explains to SciDev.Net.

Link to SciDev.Net